0.6300
-0.2320
(-26.91%)
As of 8:09:03 AM GMT+1. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ALISKI WILLIAM E Director | Stock Award(Grant) | Jun 10, 2024 | 96,667 |
ARBET-ENGELS CHRISTOPHE Officer | Sale | Jan 24, 2025 | 14,207 |
BALDRY MARK Officer | Sale | Jan 24, 2025 | 94,123 |
DIBIASE MARY Chief Operating Officer | Sale | Jan 24, 2025 | 490,980 |
LAWTON ALISON FRANCES Director | Stock Award(Grant) | Jun 10, 2024 | 96,667 |
MCGIRR DAVID W J Director | Stock Award(Grant) | Jun 10, 2024 | 96,667 |
MOSTAFA ADAM S. Chief Financial Officer | Sale | Jan 24, 2025 | 0 |
RAGAN PAULA Chief Executive Officer | Sale | Jan 24, 2025 | 1,087,390 |
TAVERAS ARTHUR PHD Officer | Sale | Oct 7, 2024 | 388,026 |
WYZGA MICHAEL S Director | Stock Award(Grant) | Jun 10, 2024 | 121,667 |
Related Tickers
YP2A.F BioLineRx Ltd.
0.0745
+46.08%
GNRO.PA GeNeuro SA
0.1430
-12.54%
37Z.BE Allakos Inc
0.1969
-2.62%
0K4.F Akero Therapeutics, Inc.
53.02
+2.71%
BLRX.TA BioLineRx Ltd.
2.4000
-25.00%
ATHA Athira Pharma, Inc.
0.5310
-0.56%
RNTX Rein Therapeutics Inc.
2.0000
+1.01%
TARA Protara Therapeutics, Inc.
4.8200
+7.11%
ACHV Achieve Life Sciences, Inc.
3.2800
+1.23%
PLRZ Polyrizon Ltd.
1.1300
-14.39%